Tennessee Senate Bill SB2274

Tennessee 2023-2024 Regular Session

• Introduced: 1/30/24
• Engrossed: 3/25/24
• Enrolled: 4/16/24
• Passed: 5/1/24
• Chaptered: 5/13/24

Caption

AN ACT to amend Tennessee Code Annotated, Title 47, Chapter 18; Title 56; Title 63 and Title 71, relative to prescription drugs.

Impact

The implications of SB 2274 on state laws are significant as it introduces an obligation for pharmacists to disclose pricing options, which could reshape practices within the pharmacy profession. By fostering an environment where pricing information is readily available, the bill supports increased competition among suppliers and may drive down costs for consumers. Additionally, it includes provisions that grant pharmacies immunity from civil liability related to the communication of pricing information, aiming to protect them from potential legal repercussions stemming from the implementation of these new responsibilities.

Summary

Senate Bill 2274 aims to amend the Tennessee Code regarding prescription drugs, with a focus on enhancing price transparency for patients. The bill encourages pharmacies and other authorized dispensing entities to notify patients or their representatives of the lowest available cost of medications, including generic alternatives, before finalizing a sale. This initiative seeks to empower consumers to make more informed choices about their prescriptions, potentially lowering their out-of-pocket costs through the use of discount programs or different suppliers.

Sentiment

Overall, sentiment around SB 2274 appears to be positive, with many stakeholders acknowledging the need for greater transparency in prescription drug pricing. Supporters of the bill argue that it is a crucial step toward addressing the challenges faced by consumers in the current healthcare environment, which is often marked by confusing price structures. However, some may express concerns about the practicality of implementing such a system, including potential burdens placed on pharmacies and the accuracy of pricing information being communicated.

Contention

Notable points of contention surrounding SB 2274 relate primarily to its implementation and the extent of the pharmacies' responsibilities. While the intention is to enhance consumer awareness and choice, questions arise about how effectively pharmacies will be able to communicate this information and whether the law will truly lead to significant cost savings. Additionally, while the immunity provision may protect pharmacies, it raises discussions about accountability if patients are led to make unfavorable purchasing decisions based on the information provided.